09:51 AM EST - ADVAN/Z PHARMA Corp. : Announced its financial and operational results for the three and 12 months ended December 31, 2019. All financial references are in U.S. dollars unless otherwise noted. 2019 revenue of $508 million, fourth quarter 2019 revenue of $122 million. 2019 net loss was $196 million and fourth quarter net loss was $25 million. 2019 Adjusted EBITDA came in at $234 million and fourth quarter 2019 Adjusted EBITDA of $53 million. Generated cash flow from operations of $188 million in 2019 and concluded the year with a cash and cash equivalents balance of $261 million ADVAN/Z PHARMA Corp.
shares T.ADVZ are trading up $0.59 at $9.29.
